Risks and burdens in the study participation, as well as an adequate risk-benefit balance, are key concepts for the evaluation of clinical studies by research ethics committees (RECs). An adequate ...

Bloomberg’s award-winning solution for Liquidity Assessment (LQA) leverages Bloomberg’s robust financial data sets to provide data-driven quantitative evaluation of market liquidity across ...

The more information we have, the more robust our assessment—and ultimately our rating and review—can be. If there isn't enough information to inform our sociotechnical assessment, and publicly ...